{"title":"Treatment of asthma including intractable one; our challenge as a pharma and beyond","authors":"Ishii Takeo","doi":"10.1254/jpssuppl.95.0_2-s27-1","DOIUrl":null,"url":null,"abstract":"Severe asthma, a part of difficult-to-treat asthma, represents a poorly controlled asthma despite maximally optimized treatment and its adherence. Uncontrolled asthma is judged by poor symptom control, frequent exacerbations requiring oral corticosteroids (OCS), or severe exacerbations requiring hospitalization. It is considered to be 5 percent or less of all asthmatics (GINA 2019).","PeriodicalId":20464,"journal":{"name":"Proceedings for Annual Meeting of The Japanese Pharmacological Society","volume":"74 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings for Annual Meeting of The Japanese Pharmacological Society","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1254/jpssuppl.95.0_2-s27-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Severe asthma, a part of difficult-to-treat asthma, represents a poorly controlled asthma despite maximally optimized treatment and its adherence. Uncontrolled asthma is judged by poor symptom control, frequent exacerbations requiring oral corticosteroids (OCS), or severe exacerbations requiring hospitalization. It is considered to be 5 percent or less of all asthmatics (GINA 2019).
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
